Need a specific person's email?
Browse Meissa Vaccines's employee directory (about 11 employees) and reveal verified emails free.
Meissa Vaccines's most common email format is First.Last@meissavaccines.com (ex. John.Doe@meissavaccines.com), used for 86% of meissavaccines.com addresses. Meissa Vaccines uses 3 email patterns.
| Format | Example | Share of meissavaccines.com |
|---|---|---|
| First.Last@meissavaccines.comMost common | John.Doe@meissavaccines.com | |
| FirstLast@meissavaccines.com | JohnDoe@meissavaccines.com | |
| FirLast@meissavaccines.com | JohDoe@meissavaccines.com |
Browse Meissa Vaccines's employee directory (about 11 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States11-50 Employees
Meissa Vaccines is a private biotechnology company focused on developing vaccines to prevent respiratory viral infections. It seeks to improve live attenuated vaccines through a proprietary design approach, under an exclusive license from Emory University and Children’s Healthcare of Atlanta. The company operates as a resident at Johnson & Johnson Innovation’s JLABS in South San Francisco and is based in Redwood City, California. Its program includes MV-012-968, an intranasal live attenuated vaccine candidate aimed at protecting infants and young children from RSV. In August 2023, Meissa reported positive safety and immunogenicity data for MV-012-968. The company operates in the biotechnology sector focused on vaccines for respiratory viruses, including intranasal delivery approaches.
Most common format
First.Last@meissavaccines.com
Example: John.Doe@meissavaccines.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.